Curosurf 3ml (Poractant Alfa Vials) 240mg/3ml (80 mg/ml)

Curosurf 3ml (Poractant Alfa) is a natural lung surfactant used to treat respiratory distress in premature infants. This sterile vial delivers 240mg of poractant alfa in 3ml for intratracheal administration. Store between 2-8°C to maintain stability. Suitable for neonatal intensive care settings.

Strength

240mg/3ml (80 mg/ml)

Pack Size

Storage

2-8°

Manufacturer / TM Owner

Chiesi Farmaceutici S.p.A.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Poractant Alfa is used to provide respiratory support for preterm infants with surfactant deficiency. It helps reduce the severity of respiratory distress syndrome by improving lung function. This medication is administered directly into the lungs to assist breathing in newborns requiring mechanical ventilation. It is specifically designed for infants born before their lungs have fully developed surfactant.

Side Effects

Curosurf works by replacing missing surfactant in the lungs, which helps the alveoli stay open and improves oxygen exchange. This can lead to easier breathing and reduced need for high levels of oxygen support. The effects are typically observed shortly after administration as lung compliance improves.

Precautions & Warnings

Handle Curosurf vials with care to avoid contamination. Warm the vial to room temperature before use and gently shake to ensure uniform suspension. Administer only under medical supervision in a clinical setting. Monitor infants closely for signs of adverse reactions during and after administration.

Avoid Interactions

No specific drug interactions have been established for poractant alfa. However, concurrent use of other medications should be carefully managed by healthcare professionals. Always inform medical staff of all medications the infant is receiving before administration. No known interactions with common neonatal medications have been reported.

Frequently Asked Questions

Curosurf 3ml is used to treat respiratory distress syndrome in premature infants by replacing missing lung surfactant.

Curosurf is administered directly into the trachea by healthcare professionals using a specialized procedure.

No, Curosurf should be stored refrigerated between 2-8°C and warmed to room temperature before use.

Curosurf is prescribed for preterm infants with surfactant deficiency under strict medical supervision.

Possible side effects may include changes in heart rate or blood pressure during administration.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.